PharmaAudioconference: Agenda

Audioconference Agenda

An Analysis of the New OIG Model Compliance Guidance for the Pharmaceutical Industry

Wednesday, May 21, 2003

7:00 am - 8:30 am H/AST (Hawaii-Aleutian)
9:00 am - 10:30 am ADT (Alaska)
10:00 am-11:30 am PDT (and Arizona)
11:00 am-12:30 pm MDT
12:00 pm-1:30 pm CDT
1:00 pm-2:30 pm EDT

The Audioconference agenda is set forth in Eastern Daylight Time below:
1:00 pm	Welcoming Remarks and Introduction of Faculty Brent Saunders, JD, MBA PricewaterhouseCoopers Analysis of the OIG Compliance Program Guidance for Pharmaceutical Manufacturers http://www.pharmacongress.com/pwcanalysis.pdf
1:05 pm	OIG Summary of and Remarks on Final Pharmaceutical Industry Guidance Mary Riordan, Esq. OIG Model Compliance Guidance for the Pharmaceutical Industry http://oig.hhs.gov/fraud/docs/complianceguidance/042803pharmacymfgnonfr.pdf
1:25 pm	In-Depth Analysis: Key Provisions in the Final Guidance, Including Program Structure and Risk Areas John Bentivoglio, Esq. Presentation Materials in Powerpoint or Acrobat Additional Materials - HHS OIG Guidance Raises Concerns
1:45 pm	In-Depth Analysis: How to Operationalize the Guidance In A Pharmaceutical Company Doug Lankler, Esq. Presentation Materials in Powerpoint or Acrobat
2:05 pm	In-Depth Analysis: What the Guidance Says About the PhRMA Code Scott Lassman, Esq. PhRMA Code on Interactions with Healthcare Professionals http://www.phrma.org/publications/policy//2002-04-19.391.pdf
2:25 pm	Questions and Answers
2:45 pm	Audioconference Adjournment